Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
INTRO SPECIAL $879 FOR 12 SHOTS
For a lot of people, these uncomfortable side effects are enough to change how they take their medicationor whether they keep taking it at all
Telehealth Advantages : Access healthcare services swiftly from your home, avoiding clinic visits
It can be self-injected under the skin once a month (adults, children) or once every three months (adults only)
References Jastreboff AM, et al, Triple-Hormone-Receptor Agonist Retatrutide for Obesity, a Phase 2 Trial, New England Journal of Medicine, 2023 Bajaj HS, et al, Efficacy and Safety of Retatrutide in Type 2 Diabetes, TRANSCEND-T2D-1, a Phase 3 Trial, The Lancet, 2026 Giblin K, Kaplan LM, Somers VK, et al, Retatrutide for the Treatment of Obesity, Obstructive Sleep Apnea and Knee Osteoarthritis, Rationale and Design of the TRIUMPH Registrational Clinical Trials, Diabetes, Obesity and Metabolism, 2026 ClinicalTrials.gov, TRIUMPH-1 trial registry entry, NCT05929066 Eli Lilly and Company, TRIUMPH-1 Phase 3 topline results announcement, May 2026 Eli Lilly and Company, TRIUMPH-4 Phase 3 trial results announcement, December 2025 Eli Lilly and Company, TRANSCEND-T2D-1 Phase 3 topline results announcement, March 2026 Central Drugs Standard Control Organisation, Subject Expert Committee meeting record on retatrutide Phase 3 trial permission, 2024 Medically reviewed by This guide was checked for medical accuracy by our review board before publishing
